ArticleJournal of Korean medical science2026
Multi-Omics and Machine Learning Analyses Reveal PIK3CG, PRKCD, and TRIM22 as Potential Markers of Poor Prognosis and Immune Activation in Glioblastoma.
Myung-Hoon Han et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.